| 000 | 01911 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515061845.0 | ||
| 264 | 0 | _c20070918 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2006.063834 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatsui, Toshihiro | |
| 245 | 0 | 0 |
_aDisease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cSep 2007 |
||
| 300 |
_a1221-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBlood Sedimentation |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKuga, Yoshiaki | |
| 700 | 1 | _aKaneko, Atsushi | |
| 700 | 1 | _aNishino, Jinju | |
| 700 | 1 | _aEto, Yoshito | |
| 700 | 1 | _aChiba, Noriyuki | |
| 700 | 1 | _aYasuda, Masayuki | |
| 700 | 1 | _aSaisho, Koichiro | |
| 700 | 1 | _aShimada, Kota | |
| 700 | 1 | _aTohma, Shigeto | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 66 _gno. 9 _gp. 1221-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2006.063834 _zAvailable from publisher's website |
| 999 |
_c16924443 _d16924443 |
||